Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response.
Fernando Sebastian-VallesJosé Alfonso Arranz MartínRosa María GirónCarolina Knott-TorcalMiguel Antonio Sampedro-NuñezJose Carlos Martin-AdanJessica Jiménez-DíazMónica MarazuelaPublished in: Biomedicines (2023)
CGM is a useful tool that offers valuable information for both the diagnosis and the management of CFRD. Lower plasma insulin levels during OGTTs are associated with a poor ambulatory glucose profile in CGM. Sitagliptin could play an important role in the treatment of the early stages of CFRD.